Shariq Ahmad Wani*, Mohammed Sharfraz Ahamed, Shruthi Jayaram, and Shariq R. Masoodi
Sodium glucose co-transporter-2 inhibitors are associated with a range of adverse effects including Diabetic ketoacidosis both euglycemic and Hyperglycemic. However, this case report highlights a rare case of DKA/HHS overlap in a patient who was treated with SGLT2i. Most patients recover with prompt recognition and treatment, patient education about identifying early signs remains a cornerstone of early identification and treatment.
PDFShare this article
Clinical and Medical Case Reports received 40 citations as per Google Scholar report
